Zacks Research Increases Earnings Estimates for HealthEquity

HealthEquity, Inc. (NASDAQ:HQY) – Stock analysts at Zacks Research lifted their FY2026 EPS estimates for HealthEquity in a research note issued to investors on Wednesday, December 24th. Zacks Research analyst Team now forecasts that the company will earn $3.31 per share for the year, up from their previous forecast of $3.20. The consensus estimate for HealthEquity’s current full-year earnings is $2.32 per share.

HQY has been the topic of several other research reports. BTIG Research restated a “buy” rating and set a $130.00 price objective on shares of HealthEquity in a research note on Thursday, December 4th. Wall Street Zen lowered HealthEquity from a “buy” rating to a “hold” rating in a research report on Saturday, November 15th. Citigroup restated an “outperform” rating on shares of HealthEquity in a research note on Thursday, December 4th. BMO Capital Markets reaffirmed a “market perform” rating on shares of HealthEquity in a report on Thursday, December 4th. Finally, Citizens Jmp increased their target price on shares of HealthEquity from $117.00 to $122.00 and gave the stock a “market outperform” rating in a report on Thursday, December 4th. Two equities research analysts have rated the stock with a Strong Buy rating, twelve have given a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $120.27.

HealthEquity Stock Performance

Shares of HQY stock opened at $92.50 on Monday. The stock has a market capitalization of $7.90 billion, a price-to-earnings ratio of 42.43, a PEG ratio of 1.34 and a beta of 0.18. HealthEquity has a one year low of $74.07 and a one year high of $116.65. The company’s 50-day simple moving average is $97.20 and its 200-day simple moving average is $95.57. The company has a debt-to-equity ratio of 0.46, a quick ratio of 4.13 and a current ratio of 4.13.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings data on Wednesday, December 3rd. The company reported $1.01 EPS for the quarter, beating analysts’ consensus estimates of $0.90 by $0.11. The firm had revenue of $322.16 million for the quarter, compared to the consensus estimate of $320.92 million. HealthEquity had a net margin of 14.86% and a return on equity of 12.94%. The firm’s revenue was up 7.2% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.78 EPS. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS.

Insider Buying and Selling at HealthEquity

In other news, EVP Michael Henry Fiore sold 1,781 shares of the business’s stock in a transaction dated Tuesday, October 7th. The shares were sold at an average price of $88.21, for a total value of $157,102.01. Following the completion of the sale, the executive vice president owned 49,795 shares of the company’s stock, valued at approximately $4,392,416.95. The trade was a 3.45% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Elimelech Rosner sold 10,959 shares of the firm’s stock in a transaction that occurred on Thursday, December 18th. The stock was sold at an average price of $95.45, for a total transaction of $1,046,036.55. Following the transaction, the executive vice president directly owned 45,742 shares in the company, valued at $4,366,073.90. This represents a 19.33% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 17,240 shares of company stock worth $1,640,164 over the last quarter. 1.50% of the stock is currently owned by insiders.

Institutional Investors Weigh In On HealthEquity

Institutional investors have recently added to or reduced their stakes in the business. Tudor Investment Corp ET AL lifted its holdings in shares of HealthEquity by 2.0% during the third quarter. Tudor Investment Corp ET AL now owns 9,698 shares of the company’s stock worth $919,000 after purchasing an additional 189 shares during the period. IFP Advisors Inc raised its position in HealthEquity by 1,602.3% during the 3rd quarter. IFP Advisors Inc now owns 749 shares of the company’s stock worth $75,000 after purchasing an additional 705 shares during the last quarter. Swiss Life Asset Management Ltd lifted its holdings in HealthEquity by 78.6% during the 3rd quarter. Swiss Life Asset Management Ltd now owns 3,992 shares of the company’s stock worth $378,000 after buying an additional 1,757 shares during the period. Penn Capital Management Company LLC increased its stake in shares of HealthEquity by 7.0% in the third quarter. Penn Capital Management Company LLC now owns 15,363 shares of the company’s stock valued at $1,479,000 after buying an additional 1,004 shares during the period. Finally, CIBC Bancorp USA Inc. bought a new position in shares of HealthEquity during the third quarter worth about $862,000. 99.55% of the stock is owned by institutional investors.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.